ArticleCancer biology & therapy2020

GSK343 induces programmed cell death through the inhibition of EZH2 and FBP1 in osteosarcoma cells.

Xifeng Xiong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.